Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.
Author: Karen Weintraub, USA TODAY
AstraZeneca may have used outdated information in COVID-19 vaccine trial, US health officials say
Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have used “outdated information,” U.S. federal health officials said early Tuesday.
AstraZeneca says US data shows COVID-19 vaccine prevents 79% of symptomatic disease
AstraZeneca’s vaccine had a 79% efficacy rate at preventing symptomatic COVID-19 and was 100% effective in stopping severe disease and hospitalization
‘It’s easy to scare people’: Europe’s decision to pull AstraZeneca-Oxford vaccine threatens global COVID-19 recovery efforts, US experts say
As AstraZeneca defends its COVID-19 vaccine following a European pause, the World Health Organization says there is no reason to stop using it.
People with immune issues – at ‘high risk’ for COVID-19 – remain hesitant about vaccination. Here’s what experts say.
Organizations representing experts in cancer, organ transplantation and autoimmune diseases support COVID-19 vaccination for their patients.
What science has learned works and what doesn’t in COVID treatments
A year into treating those with COVID-19, research is revealing medical interventions, such as remdesivir, that help patients, and some that don’t.
People who’ve had COVID-19 might only need to get vaccinated once, studies suggest
Six recent studies suggest that people who’ve already come down with COVID-19 might not need to get a second vaccine dose.
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The Food and Drug Administration is expected to act quickly to authorize J&J’s one-dose COVID-19 vaccine after an advisory panel meets Friday.
One-dose J&J COVID-19 vaccine meets criteria as safe and effective, FDA report finds
A key FDA committee meets Friday to review the one-dose COVID vaccine from J&J. Authorization for its use in the US is expected to swiftly follow.
Why get COVID-19 vaccination if you still have to wear a mask? It beats getting sick, health experts say.
Getting two shots of either the Moderna or Pfizer-BioNTech vaccine reduces risk of developing symptomatic COVID-19 by about 95%, but not completely.